Rick Doblin at the 2023 Psychedelic Science conference in Denver (Courtesy of Psychedelic Science and MAPS)

September 17, 2024 10:00 AM EDT

Bad trip: How culture conflict and a need for cash nearly broke Lykos

Max Bayer

Pharma Reporter

In early 2023, the founder of the psychedelic medicine company Lykos Therapeutics met with a potential investor for dinner, feeling out the chemistry for a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Bad trip: How culture conflict and a need for cash nearly broke Lykos

Max Bayer

Pharma Reporter

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Here's what today's Fed rate cut means for biotech, pharma and venture capital

FDA cancels Applied Therapeutics adcomm, shares skyrocket 65%

All of 23andMe's independent board members resign over disagreements with CEO

You bet your life: After I was diagnosed with a rare cancer, I discovered how a small band of physician-scientists ...

With few efficacy details, Insilico claims a Phase 2a win in latest AI readout

Breaking down silos with a new quantitative approach to drug development

Bad trip: How cul­ture con­flict and a need for cash near­ly broke Lykos

Pharma Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Bad trip: How culture conflict and a need for cash nearly broke Lykos